MEDB-74. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies

Nearly one-third of children with medulloblastoma, a malignant embryonal tumor of the cerebellum, succumb to their disease. Conventional response monitoring by imaging and cerebrospinal fluid (CSF) cytology remains challenging and a marker for measurable residual disease (MRD) is lacking. Here, we s...

Descripción completa

Detalles Bibliográficos
Autores principales: Northcott, Paul, Smith, Kyle, Kumar, Rahul, Paul, Leena, Bihannic, Laure, Lin, Tong, Maass, Kendra, Pajtler, Kristian, Chintagumpala, Murali, Su, Jack, Bouffet, Eric, Fisher, Michael, Gururangan, Sridharan, Cohn, Richard, Hassall, Tim, Hansford, Jordan, Klimo, Paul, Boop, Frederick, Stewart, Clinton, Harreld, Julie, Merchant, Thomas, Tatevossian, Ruth, Neale, Geoffrey, Lear, Matthew, Klco, Jeffery, Orr, Brent, Ellison, David, Gilbertson, Richard, Onar-Thomas, Arzu, Gajjar, Amar, Robinson, Giles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Medulloblastoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164954/
http://dx.doi.org/10.1093/neuonc/noac079.448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164954/
http://dx.doi.org/10.1093/neuonc/noac079.448

Ejemplares similares